Tanguler Tolga, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals ($ALNY), sold shares on the open market 66 times over the past year, totaling $5.25 million. His most recent sale occurred on March 4, 2026. These sales rank 1,860th among 11,678 insiders in our database, where the average is $8.6 million across about 6 transactions per insider. Tolga made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 350 | $323.01 | 35,544.0000 | 134,684,000 | 0.98% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 289 | $321.82 | 35,894.0000 | 134,684,000 | 0.80% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 215 | $320.81 | 36,183.0000 | 134,684,000 | 0.59% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 102 | $320.01 | 36,398.0000 | 134,684,000 | 0.28% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 106 | $319.03 | 36,500.0000 | 134,684,000 | 0.29% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 208 | $325.67 | 34,297.0000 | 134,684,000 | 0.60% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 272 | $324.88 | 34,505.0000 | 134,684,000 | 0.78% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 767 | $323.84 | 34,777.0000 | 134,684,000 | 2.16% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 392 | $326.81 | 37,417.0000 | 134,684,000 | 1.04% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 258 | $325.63 | 37,809.0000 | 134,684,000 | 0.68% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 90 | $324.65 | 38,067.0000 | 134,684,000 | 0.24% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 4769 | $0.00 | 38,204.0000 | 134,684,000 | 14.26% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 47 | $323.62 | 38,157.0000 | 134,684,000 | 0.12% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Stock Option (right to buy) | 10480 | $0.00 | 10,480.0000 | 134,684,000 | 9999.99% | 0.01% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 37 | $332.64 | 36,606.0000 | 134,684,000 | 0.10% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 94 | $331.93 | 36,643.0000 | 134,684,000 | 0.26% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 81 | $330.85 | 36,737.0000 | 134,684,000 | 0.22% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 170 | $329.71 | 36,818.0000 | 134,684,000 | 0.46% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 100 | $328.71 | 36,988.0000 | 134,684,000 | 0.27% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 329 | $327.67 | 37,088.0000 | 134,684,000 | 0.88% | 0.00% |
| Feb. 27, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | M | Restricted Stock Units | 1666 | $0.00 | 0.0000 | 134,684,000 | 100.00% | 0.00% |
| Feb. 27, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | M | Common Stock | 1666 | $0.00 | 33,435.0000 | 134,684,000 | 5.24% | 0.00% |
| Feb. 13, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 1959 | $310.08 | 31,769.0000 | 134,684,000 | 5.81% | 0.00% |
| Feb. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 4000 | $0.00 | 33,728.0000 | 134,684,000 | 13.46% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 47 | $363.55 | 30,439.0000 | 134,684,000 | 0.15% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 15 | $377.82 | 29,728.0000 | 134,684,000 | 0.05% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 19 | $375.65 | 29,743.0000 | 134,684,000 | 0.06% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 14 | $374.44 | 29,762.0000 | 134,684,000 | 0.05% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 2 | $372.46 | 29,776.0000 | 134,684,000 | 0.01% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 19 | $370.87 | 29,778.0000 | 134,684,000 | 0.06% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 40 | $369.48 | 29,797.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 92 | $368.62 | 29,837.0000 | 134,684,000 | 0.31% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 41 | $367.40 | 29,929.0000 | 134,684,000 | 0.14% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 50 | $366.41 | 29,970.0000 | 134,684,000 | 0.17% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 220 | $365.56 | 30,020.0000 | 134,684,000 | 0.73% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 199 | $364.83 | 30,240.0000 | 134,684,000 | 0.65% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 73 | $362.38 | 30,486.0000 | 134,684,000 | 0.24% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 98 | $361.45 | 30,559.0000 | 134,684,000 | 0.32% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 155 | $360.22 | 30,657.0000 | 134,684,000 | 0.50% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 85 | $359.14 | 30,812.0000 | 134,684,000 | 0.28% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 123 | $358.18 | 30,897.0000 | 134,684,000 | 0.40% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 96 | $357.17 | 31,020.0000 | 134,684,000 | 0.31% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 41 | $356.09 | 31,116.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 42 | $355.16 | 31,157.0000 | 134,684,000 | 0.13% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 39 | $353.95 | 31,199.0000 | 134,684,000 | 0.12% | 0.00% |
| Jan. 11, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 3800 | $0.00 | 31,238.0000 | 134,684,000 | 13.85% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 55 | $446.53 | 28,788.0000 | 137,348,000 | 0.19% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 1 | $457.64 | 27,438.0000 | 137,348,000 | 0.00% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 70 | $457.43 | 27,439.0000 | 137,348,000 | 0.25% | 0.00% |
| Oct. 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 2851 | $0.00 | 28,843.0000 | 137,348,000 | 10.97% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 35 | $455.82 | 27,509.0000 | 137,348,000 | 0.13% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 117 | $454.84 | 27,544.0000 | 137,348,000 | 0.42% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 157 | $453.77 | 27,661.0000 | 137,348,000 | 0.56% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 319 | $452.69 | 27,818.0000 | 137,348,000 | 1.13% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 159 | $451.86 | 28,137.0000 | 137,348,000 | 0.56% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 260 | $450.81 | 28,296.0000 | 137,348,000 | 0.91% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 119 | $449.79 | 28,556.0000 | 137,348,000 | 0.41% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 86 | $448.77 | 28,675.0000 | 137,348,000 | 0.30% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 27 | $447.92 | 28,761.0000 | 137,348,000 | 0.09% | 0.00% |
| Aug. 29, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 1289 | $448.05 | 27,083.0000 | 127,651,000 | 4.54% | 0.00% |
| Aug. 29, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 195 | $445.53 | 29,271.0000 | 127,651,000 | 0.66% | 0.00% |
| Aug. 29, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 899 | $446.98 | 28,372.0000 | 127,651,000 | 3.07% | 0.00% |
| Aug. 29, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 681 | $449.54 | 26,402.0000 | 127,651,000 | 2.51% | 0.00% |
| Aug. 29, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 266 | $451.52 | 26,136.0000 | 127,651,000 | 1.01% | 0.00% |
| Aug. 29, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 144 | $452.49 | 25,992.0000 | 127,651,000 | 0.55% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 12 | $455.82 | 29,466.0000 | 127,651,000 | 0.04% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 39 | $447.98 | 30,823.0000 | 127,651,000 | 0.13% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 39 | $450.92 | 30,694.0000 | 127,651,000 | 0.13% | 0.00% |
| Aug. 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 2851 | $0.00 | 30,862.0000 | 127,651,000 | 10.18% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 90 | $449.92 | 30,733.0000 | 127,651,000 | 0.29% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 103 | $451.99 | 30,591.0000 | 127,651,000 | 0.34% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 329 | $452.96 | 30,262.0000 | 127,651,000 | 1.08% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 543 | $454.04 | 29,719.0000 | 127,651,000 | 1.79% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 241 | $454.84 | 29,478.0000 | 127,651,000 | 0.81% | 0.00% |
| June 26, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Tanguler Tolga | Not found | A | Stock Option (right to buy) | 14583 | $0.00 | 14,583.0000 | 33,196,997 | 9999.99% | 0.04% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 70 | $245.26 | 28,043.0000 | 127,651,000 | 0.25% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 14137 | $0.00 | 28,482.0000 | 127,651,000 | 98.55% | 0.01% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 131 | $242.37 | 28,351.0000 | 127,651,000 | 0.46% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 142 | $243.36 | 28,209.0000 | 127,651,000 | 0.50% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 96 | $244.41 | 28,113.0000 | 127,651,000 | 0.34% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 29 | $246.18 | 28,014.0000 | 127,651,000 | 0.10% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 3 | $247.35 | 28,011.0000 | 127,651,000 | 0.01% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Stock Option (right to buy) | 7819 | $0.00 | 7,819.0000 | 127,651,000 | 9999.99% | 0.01% |
| Feb. 27, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 14,858.0000 | 127,651,000 | 12.64% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 28 | $236.51 | 14,830.0000 | 127,651,000 | 0.19% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 22 | $238.33 | 14,808.0000 | 127,651,000 | 0.15% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 23 | $239.18 | 14,785.0000 | 127,651,000 | 0.16% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 50 | $240.32 | 14,735.0000 | 127,651,000 | 0.34% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 82 | $241.51 | 14,653.0000 | 127,651,000 | 0.56% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 192 | $242.44 | 14,461.0000 | 127,651,000 | 1.31% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 78 | $243.23 | 14,383.0000 | 127,651,000 | 0.54% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 38 | $244.11 | 14,345.0000 | 127,651,000 | 0.26% | 0.00% |
| Feb. 27, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 1,666.0000 | 127,651,000 | 50.02% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 826 | $251.42 | 13,275.0000 | 128,590,000 | 5.86% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 84 | $252.27 | 13,191.0000 | 128,590,000 | 0.63% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 318 | $250.68 | 14,101.0000 | 128,590,000 | 2.21% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 215 | $249.60 | 14,419.0000 | 128,590,000 | 1.47% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 26 | $247.77 | 14,634.0000 | 128,590,000 | 0.18% | 0.00% |
| Nov. 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 3000 | $0.00 | 14,660.0000 | 128,590,000 | 25.73% | 0.00% |
| Nov. 11, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Tanguler Tolga | Not found | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 59 | $221.71 | 13,206.0000 | 124,906,000 | 0.44% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 13 | $224.17 | 13,193.0000 | 124,906,000 | 0.10% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 18 | $225.55 | 13,175.0000 | 124,906,000 | 0.14% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 34 | $226.82 | 13,141.0000 | 124,906,000 | 0.26% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 129 | $228.30 | 13,012.0000 | 124,906,000 | 0.98% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 266 | $229.06 | 12,746.0000 | 124,906,000 | 2.04% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 304 | $229.93 | 12,442.0000 | 124,906,000 | 2.39% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 99 | $231.59 | 12,343.0000 | 124,906,000 | 0.80% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 216 | $232.54 | 12,127.0000 | 124,906,000 | 1.75% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 115 | $233.53 | 12,012.0000 | 124,906,000 | 0.95% | 0.00% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 3278 | $0.00 | 13,265.0000 | 124,906,000 | 32.82% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 167 | $235.19 | 11,660.0000 | 124,906,000 | 1.41% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 185 | $234.66 | 11,827.0000 | 124,906,000 | 1.54% | 0.00% |
| March 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Stock Option (right to buy) | 9279 | $0.00 | 9,279.0000 | 124,906,000 | 9999.99% | 0.01% |
| March 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 4751 | $0.00 | 9,987.0000 | 124,906,000 | 90.74% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 216 | $154.54 | 5,521.0000 | 124,906,000 | 3.77% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 170 | $155.45 | 5,351.0000 | 124,906,000 | 3.08% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 100 | $156.38 | 5,251.0000 | 124,906,000 | 1.87% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 14 | $157.30 | 5,237.0000 | 124,906,000 | 0.27% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 1 | $158.09 | 5,236.0000 | 124,906,000 | 0.02% | 0.00% |
| Feb. 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 3,333.0000 | 124,906,000 | 33.34% | 0.00% |
| Feb. 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 5,737.0000 | 124,906,000 | 40.96% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 519 | $148.24 | 4,191.0000 | 124,906,000 | 11.02% | 0.00% |
| Feb. 15, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | A | Common Stock | 3278 | $0.00 | 5,079.0000 | 124,906,000 | 182.01% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 369 | $147.50 | 4,710.0000 | 124,906,000 | 7.27% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Tanguler Tolga | EVP, Chief Commercial Officer | S | Common Stock | 121 | $149.03 | 4,070.0000 | 124,906,000 | 2.89% | 0.00% |